GeneOne Life Science, Inc. (KRX:011000)
South Korea
· Delayed Price · Currency is KRW
2,065.00
-10.00 (-0.48%)
Last updated: Dec 5, 2025, 10:27 AM KST
GeneOne Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 176,365 | 168,840 | 222,271 | 553,651 | 1,250,928 | 961,062 | |
| Market Cap Growth | -5.79% | -24.04% | -59.85% | -55.74% | 30.16% | 1733.31% | |
| Enterprise Value | 204,043 | 188,532 | 219,584 | 509,945 | 1,241,186 | 881,347 | |
| Last Close Price | 2070.00 | 2115.00 | 2840.00 | 7140.00 | 16200.00 | 13850.76 | |
| PS Ratio | 5.71 | 4.73 | 5.53 | 11.36 | 32.32 | 23.16 | |
| PB Ratio | 3.19 | 1.97 | 1.99 | 3.05 | 6.06 | 9.76 | |
| P/TBV Ratio | 3.20 | 1.98 | 2.00 | 3.06 | 6.08 | 9.82 | |
| EV/Sales Ratio | 6.60 | 5.28 | 5.46 | 10.47 | 32.07 | 21.24 | |
| Debt / Equity Ratio | 0.55 | 0.32 | 0.15 | 0.11 | 0.09 | 0.18 | |
| Asset Turnover | 0.23 | 0.24 | 0.22 | 0.21 | 0.20 | 0.44 | |
| Inventory Turnover | 2.76 | 2.97 | 3.23 | 3.10 | 3.17 | 3.55 | |
| Quick Ratio | 0.14 | 0.24 | 0.77 | 1.66 | 3.36 | 2.68 | |
| Current Ratio | 0.50 | 0.67 | 1.51 | 2.16 | 3.87 | 2.96 | |
| Return on Equity (ROE) | -71.52% | -49.25% | -53.09% | -19.67% | -10.42% | -30.43% | |
| Return on Assets (ROA) | -19.32% | -17.79% | -16.17% | -10.61% | -8.88% | -12.34% | |
| Return on Capital (ROIC) | -25.83% | -22.29% | -18.33% | -11.79% | -10.08% | -14.96% | |
| Return on Capital Employed (ROCE) | -52.60% | -39.50% | -37.70% | -21.30% | -12.70% | -18.60% | |
| Earnings Yield | -29.12% | -28.75% | -34.99% | -6.89% | -1.27% | -1.94% | |
| FCF Yield | -9.71% | -11.46% | -12.30% | -12.54% | -6.98% | -3.34% | |
| Buyback Yield / Dilution | -3.64% | -2.20% | -0.34% | -4.37% | -22.98% | -88.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.